Search
When the BumR gives you diarrhea - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/when-the-bumr-gives-you-diarrhea.html
A study from UT Southwestern researchers sheds new light on how the bug that’s the No. 1 cause of bacterial diarrhea finds its way through the human gut.
How cancer cells stiff-arm normal environmental cues to consume energy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/how-cancer-cells-consume-energy.html
UT Southwestern researchers have uncovered how cells in general modulate their energy consumption based on their surroundings.
High-sugar diet can damage the gut, intensifying risk for colitis : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/high-sugar-diet-can-damage-the-gut.html
Mice fed diets high in sugar developed worse colitis, a type of inflammatory bowel disease (IBD), and researchers examining their large intestines found more of the bacteria that can damage the gut’s protective mucus layer.
The secret of lymph: How lymph nodes help cancer cells spread : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/lymph-nodes-help-cancer-cells-spread.html
For decades, physicians have known that many kinds of cancer cells often spread first to lymph nodes before traveling to distant organs through the bloodstream.
Obesity drugs help patients lose weight regained years after bariatric surgery : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/june-obesity-drugs-bariatric-surgery.html
Anti-obesity medications, including semaglutide (Ozempic/Wegovy), can effectively help patients manage weight regain after bariatric surgery, a study led by UT Southwestern Medical Center researchers shows.
UTSW clinical trial sets stage for new paradigm in kidney cancer treatment: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-new-paradigm-in-kidney-cancer-treatment.html
Building upon previous work at UT Southwestern Medical Center, investigators report the results of a clinical trial exploring the role of stereotactic ablative radiation therapy (SAbR) for patients with a handful of metastases, or so-called oligometastatic disease.
Children’s Research Institute at UT Southwestern identifies metabolic inflexibility that keeps damage at bay during liver regeneration: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/july-childrens-ut-liver-regeneration.html
Liver cells have a vital metabolic inflexibility during regeneration to starve dysfunctional cells and keep damage from spreading, according to new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Science.
UTSW is leading the way toward better screening for liver cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-better-screening-for-liver-cancer.html
UT Southwestern will lead a multisite initiative funded by the National Cancer Institute (NCI) to identify biomarkers to improve risk assessment and early detection of hepatocellular cancer (HCC), the most common form of liver cancer, among patients with cirrhosis.
Machine learning sheds light on gene transcription : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/may-machine-learning-gene-transcription.html
A team led by researchers at UT Southwestern Medical Center developed deep learning models to identify a simple set of rules that govern the activity of promoters – regions of DNA that initiate the process by which genes produce proteins.
Warfarin use should not disqualify stroke patients from lifesaving clot-removing surgery: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/june-lifesaving-clot-removing-surgery.html
Most stroke patients taking the anticoagulant warfarin were no more likely than those not on the medication to experience a brain bleed when undergoing a procedure to remove a blood clot, UT Southwestern Medical Center researchers report in a new study.